OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Thomas Franke

2 Projects | 1 Researchers | $256,435 Invested

2016

Icahn School of Medicine at Mount Sinai

Thomas Franke, MD, PhD

Targeting Ca2+ dysregulation in Alzheimer's Disease

  • Funding Amount: $233,505
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed

2016

New York University

Thomas Franke, MD, PhD

Targeting Ca2+ dysregulation in Alzheimer's Disease

  • Funding Amount: $22,930
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed